ARTICLE SUMMARY:
FDA’s device program increase stands out in the Trump administration’s 2021 budget request. More policies to watch in the budget, and developments in India, China, Malaysia, and Australia in this week’s Pathways’ Picks, Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news.
The Trump administration issued its fiscal 2021 budget request this week. It is assuredly more about political signaling than substantive policy development and what Congress actually passes will be different. But the request nonetheless helps underscore key dynamics and priorities of importance to medtech in the US. We spotlight some key US budget takeaways, and also report on important developments in the Asia medtech sphere, and more, in this week’s Pathway’s Picks.
